The FDA granted 510(k) clearance for iPredict-DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, according to a press release from iHealthScreen.
July 09, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
iHealthScreen Receives U.S. FDA 510(k) Clearance (K253704) for iPredict-DR, an AI-Powered Software for Automated Diabetic Retinopathy Screening
Doctors develop app-based platform to predict cardio, renal risks in diabetes patients
Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk
iHealthScreen Receives U.S. FDA 510(k) Clearance (K253704) for iPredict-DR, an AI-Powered Software for Automated Diabetic…
LAS VEGAS — Ocula360, an AI-based tool for diabetic retinopathy lesion detection, showed efficacy in detecting DR across multiple…
Find the latest Imaging and Diagnostics news articles, videos, podcasts, and meeting coverage from medical experts and key…
Of more than 1,300 AI medical devices cleared by the FDA, only three tested for patient-centered outcomes like death and…
The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by…
Home OCT combined with an AI analysis helped in the early detection of retinal fluid in patients with age-related macular…
